
UB051
TargetsGLP-1; GIP
IndicationsType 2 diabetes mellitus; Obesity; Nonalcoholic steatohepatitis
ClinicalPreclinical
TherapeuticsMetabolic & Endocrinology; Gastroenterology & Hepatology
ModalitiesPeptide
我们能如何帮助您?
获取最新活动与法规动态洞察
直接发送到您的邮箱
在此获取行业洞察与 Unibest 动态
联系我们 →